Last quarter (Q4 2023), Cipher Pharmaceuticals's total revenue was $4.92M, a decrease of -41.57% from the same quarter last year. In Q4, Cipher Pharmaceuticals's net income was $7.66M. See Cipher Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 21.16M	$ 21.16M	$ 20.68M	$ 21.94M	$ 21.61M	$ 22.45M
Cost of Revenue	$ 4.07M	$ 4.07M	$ 3.99M	$ 3.68M	$ 3.06M	$ 2.91M
Gross Profit	$ 17.09M	$ 17.09M	$ 16.68M	$ 18.26M	$ 18.55M	$ 19.55M
Operating Expense	$ 4.32M	$ 4.32M	$ 5.63M	$ 6.45M	$ 6.39M	$ 8.04M
Operating Income	$ 12.77M	$ 12.77M	$ 11.05M	$ 11.81M	$ 12.16M	$ 11.50M
Net Non Operating Interest Income Expense	$ 1.87M	$ 1.87M	$ 464.00K	$ 80.00K	$ -291.00K	$ -786.00K
Other Income Expense	-	-	-	$ -670.00K	$ -5.34M	$ -5.01M
Pretax Income	$ 15.42M	$ 15.42M	$ 11.48M	$ 11.06M	$ 6.54M	$ 5.71M
Tax Provision	$ -4.96M	$ -4.96M	$ -15.16M	$ 3.30M	$ 2.15M	$ 3.07M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 20.38M	$ 20.38M	$ 26.64M	$ 7.76M	$ 4.55M	$ 3.24M
Basic EPS	$ 0.82	$ 0.82	$ 1.05	$ 0.29	$ 0.17	$ 0.12
Diluted EPS	$ 0.80	$ 0.80	$ 1.03	$ 0.29	$ 0.17	$ 0.12
Basic Average Shares	$ 100.02M	$ 25.00M	$ 25.38M	$ 26.60M	$ 27.03M	$ 26.85M
Diluted Average Shares	$ 101.29M	$ 25.42M	$ 25.80M	$ 26.83M	$ 27.37M	$ 26.96M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 8.39M	$ 8.39M	$ 9.63M	$ -10.13M	$ 9.44M	$ 10.95M
Net Income From Continuing And Discontinued Operation	$ 20.38M	$ 20.38M	$ 26.64M	$ 7.76M	$ 4.55M	$ 3.24M
Normalized Income	$ 6.70M	$ 10.45M	$ -3.68M	$ 10.14M	$ 7.97M	$ 6.32M
Interest Expense	-	-	-	-	$ 323.00K	$ 965.00K
EBIT	$ 15.42M	$ 15.42M	$ 11.48M	$ 11.15M	$ 6.86M	$ 6.67M
EBITDA	$ 16.64M	$ 16.64M	$ 12.47M	$ 11.85M	$ 8.06M	$ 7.86M

Currency in USD

Cipher Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing